Test
340 articles
Triple Immunotherapy Shows Dramatic Results
Dr. William Freed-Pastor is testing a combination of three types of immunotherapy to attack pancreatic tumors.
New-Onset Diabetes Plus Unintentional Weight Loss Emerging as an Important Clue In Earlier Detection
Dr. Brian Wolpin outlines the connection between unintentional weight loss, new-onset diabetes, and pancreatic cancer.
Clinical Trial For OncoTreat Being Developed
Researcher Kenneth Olive is developing OncoTreat, a method matches a patient’s tumor to the most effective drugs for their pancreatic cancer.
New Clues in Pancreatic Cancer Weight Loss
Dr. Matthew Vander Heiden is researching how pancreatic tumors trigger weight loss in pancreatic cancer patients, and the relationship with survival.
Personalizing Pancreatic Cancer Treatment
Dr. Mark Ricigliano takes a closer look at the genetics of circulating tumor cells, to personalize pancreatic cancer treatment for the best results.
Safety and Effectiveness of a New Drug for Advanced Pancreatic Cancer
Researchers are testing dose safety and effectiveness of a new drug for pancreatic cancer, in combination with gemcitabine.
Learn More About Qualifying for Clinical Trials
Dr. Anup Kasi provides in-depth information and answers questions about qualifying for pancreatic cancer clinical trials.
A Year in Review: 2022 in Research
What progress was made in pancreatic treatment and screening? Learn about the major pancreatic cancer developments of 2022.